XKRX:344860 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
1,561
-100 (-6.02%)
Mar 28
What is a stock summary page? Click here for an overview.
Business Description
Innogene Co Ltd
ISIN : KR7344860002
Share Class Description:
XKRX:344860: Ordinary SharesCompare
Compare
Traded in other countries / regions
344860.Korea IPO Date
2020-04-27Description
Innogene Co Ltd is a bio-technology company. The company provides treatment solutions using stem cells and databases for hair loss, psoriasis, skin regeneration and hair follicle formation. Also, the company helps in hair loss diagnosis.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 179.97 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.07 | |||||
| Interest Coverage | 89.05 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 14.44 | |||||
| Beneish M-Score | -2.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 54.7 | |||||
| 3-Year EBITDA Growth Rate | 25.4 | |||||
| 3-Year EPS without NRI Growth Rate | 17.9 | |||||
| 3-Year FCF Growth Rate | 11.3 | |||||
| 3-Year Book Growth Rate | 33.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.71 | |||||
| 9-Day RSI | 40.73 | |||||
| 14-Day RSI | 44.42 | |||||
| 3-1 Month Momentum % | 13.42 | |||||
| 6-1 Month Momentum % | -10.63 | |||||
| 12-1 Month Momentum % | -25.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.16 | |||||
| Quick Ratio | 15.76 | |||||
| Cash Ratio | 14.46 | |||||
| Days Inventory | 218.16 | |||||
| Days Sales Outstanding | 36.04 | |||||
| Days Payable | 11.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.12 | |||||
| Dividend Payout Ratio | 1.01 | |||||
| Forward Dividend Yield % | 5.12 | |||||
| 5-Year Yield-on-Cost % | 5.12 | |||||
| 3-Year Average Share Buyback Ratio | -8.7 | |||||
| Shareholder Yield % | 5.32 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.18 | |||||
| Operating Margin % | 7.05 | |||||
| Net Margin % | 10.57 | |||||
| FCF Margin % | 9.05 | |||||
| ROE % | 5.81 | |||||
| ROA % | 5.39 | |||||
| ROIC % | 12.97 | |||||
| 3-Year ROIIC % | -362.44 | |||||
| ROC (Joel Greenblatt) % | 31.96 | |||||
| ROCE % | 5.66 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.76 | |||||
| PE Ratio without NRI | 19.76 | |||||
| PS Ratio | 2.09 | |||||
| PB Ratio | 1.13 | |||||
| Price-to-Tangible-Book | 1.13 | |||||
| Price-to-Free-Cash-Flow | 22.62 | |||||
| Price-to-Operating-Cash-Flow | 22.62 | |||||
| EV-to-EBIT | 5.7 | |||||
| EV-to-EBITDA | 4.58 | |||||
| EV-to-Revenue | 0.58 | |||||
| EV-to-FCF | 6.63 | |||||
| Price-to-GF-Value | 0.6 | |||||
| Price-to-Graham-Number | 0.99 | |||||
| Price-to-Net-Current-Asset-Value | 1.24 | |||||
| Price-to-Net-Cash | 1.49 | |||||
| Earnings Yield (Greenblatt) % | 17.53 | |||||
| FCF Yield % | 4.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Innogene Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 8,944.601 | ||
| EPS (TTM) (â‚©) | 79 | ||
| Beta | -0.17 | ||
| 3-Year Sharpe Ratio | -0.41 | ||
| 3-Year Sortino Ratio | -0.58 | ||
| Volatility % | 24.48 | ||
| 14-Day RSI | 44.42 | ||
| 14-Day ATR (â‚©) | 64.606399 | ||
| 20-Day SMA (â‚©) | 1636.45 | ||
| 12-1 Month Momentum % | -25.88 | ||
| 52-Week Range (â‚©) | 1382 - 2665 | ||
| Shares Outstanding (Mil) | 11.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Innogene Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Innogene Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Innogene Co Ltd Frequently Asked Questions
What is Innogene Co Ltd(XKRX:344860)'s stock price today?
The current price of XKRX:344860 is â‚©1561.00. The 52 week high of XKRX:344860 is â‚©2665.00 and 52 week low is â‚©1382.00.
When is next earnings date of Innogene Co Ltd(XKRX:344860)?
The next earnings date of Innogene Co Ltd(XKRX:344860) is .
Does Innogene Co Ltd(XKRX:344860) pay dividends? If so, how much?
The Dividend Yield %  of Innogene Co Ltd(XKRX:344860) is 5.12% (As of Today), Highest Dividend Payout Ratio of Innogene Co Ltd(XKRX:344860) was 1.01. The lowest was 0.25. And the median was 0.63. The  Forward Dividend Yield % of Innogene Co Ltd(XKRX:344860) is 5.12%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers